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Summsry 
FceRI is a tetrameric  receptor,  composed of a ligand  recognition  subunit,  c~, a fl chain,  and 
dimeric 3' chains.  Previous studies have indicated that  the dimeric 3~ chain is associated with 
Fc"/RIIIA (CD16) on natural killer cells and macrophages as well as the clonotypic T cell receptor. 
Here we show that in mast cells, in addition to the dimeric 3  ~  chains,  the fl subunit is associated 
not only with FceRI, but also with Fc'yRIIIA. Functional reconstitution studies with a masto- 
cytoma cell line indicate that Fc'yRIIIA composed of oe, 3, and 3~ subunits has the capacity for 
signal  transduction.  These  studies suggest  that  through  the association  of alternative  ligand 
recognition subunits (o~,, oes), a common signal transduction  complex (33'2)  mediates similar 
biochemical  and effector functions  in response to immunoglobulin  G  (IgG) and IgE. 
I 
'mmune complexes trigger diverse inflammatory and im- 
munomodulatory responses by virtue of their interaction 
with isotype-specific Fc receptors expressed on a wide array 
of  hematopoietic  cells.  Consistent  with  this  functional 
heterogeneity,  recent  studies have elucidated a comparable 
structural heterogeneity, resulting in a family of membrane 
proteins  that  differ  in  their  membrane  spanning  and  in- 
tracytoplasmic domains (1-3). Fc',/RIIIA (CD16) expressed 
on NK cells and macrophages mediates antibody-dependent 
cellular cytotoxicity and phagocytosis. FceRI on mast cells 
and basophils induces allergic reactions. Previous studies have 
indicated that Fc3~RIIIA and FceRI are closely related both 
structurally and functionally. Fc',/RIIIA-ol is associated with 
the 3' chain, which was initially identified as one subunit of 
FceRI (4-8).  Crosslinking  of either of these two receptors 
results in inositol phospholipid  hydrolysis and increases  in 
intracellular calcium (1, 9). In mast cells, both IgE and IgG 
have been shown to trigger similar responses through their 
interaction with their respective Fc receptors (10). In this study 
we demonstrate that  these two receptors share  both fl and 
3,  subunits,  differing  only  in  their  ligand  recognition  o~ 
subunit. 
Materials  and Methods 
Cell Culture and DNA  Transfection.  MC9 cells were cultured 
in DME containing mouse spleen-conditioned  medium and 10% 
FCS. COS-7 cells were cultured  in DME containing  10% FCS. 
Rat FceRI 3  subunit cDNA was isolated (11) by PCR from the 
rat basoliphic leukemia (RBL) mRNA, and cloned into the pCEXV-3 
expression vector, cDNAs (human and mouse Fc~RIIIA-oe, human 
FceRI-c~, human TCR/CD3 ~', and mouse FceRI-~/) for COS-7 
cell transfections were also cloned into pCEXV-3 (1). DNA was 
transfected into COS-7 cells using DEAE-dextran  (150/~g/ml) in 
the presence  of 100/zM chloroquine followed  by 20% glycerol shock. 
For  P815 cell  transfections,  the  plasmid  containing  human 
Fc~RIIIA-c~ and 3, cDNAs and neomycin-resistant gene was con- 
structed (pCNeo-cey), and FceRI-3 cDNA was cloned into pBabe 
Puro  expression  vector  (12). P815 cells were  transfected  with 
pCNeo-cc'y alone or a combination  of pCNeo-c~3, and 3 cDNA 
by the calcium-phosphate method,  and selected in the presence of 
G418 alone or G418 and puromycin. Clones were screened by flow 
cytometry using 3G8, and expression of the B subunit was checked 
by Western blotting analysis. 
Antibodies.  The peptide synthesized from the cytoplasmic do- 
main of mouse Fc',/RIIIA-c~ was used to raise the polyclonal anti- 
body. Antibodies against human Fc~RIIIA-c~, y, and ~" chains were 
already described (13). Antibody against 3 chain was kindly provided 
by J.-P.  Kinet  (National  Institutes  of Health) (14). 
Immunoprecipitation Analysis.  MC9 cells and transfected COS-7 
cells were iodinated with 12sI by using 1,3,4,6-tetrachloro-3c~, 6~- 
diphenylglycouril (Iodo-Gen; Pierce Chemical Co., Rockford, IL). 
Cells were solubilized in lysis buffer containing  1% digitonin and 
0.12% Triton X-100. Cell lysates were sequential incubated (2 h, 
4~  for each incubation)  with antibodies  and with protein  A- 
Sepharose or protein A-Sepharose coated with rabbit anti-mouse 
IgG antibody. For immunoblotting, samples were separated on SDS- 
polyacrylamide gels and transferred to an Immobilon-P sheet (Mil- 
lipore Continental Water Systems, Bedford, MA). Membranes were 
incubated with lzSI-labeled anti-3 antibody or with mAb IgG2bk 
(antiphosphotyrosine  antibody; Upstate Biotechnology Inc., Lake 
Placid,  NY)  followed by alkaline phosphatase-conjugated  goat 
anti-mouse IgG. 
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phate Generation, and Tyrosine Phophorylation.  For [Ca2+]i measure- 
ments, the cells were incubated  at 37~  for 45 min in 20 mM Hepes 
buffer (pH 7.5) containing 5 mM glucose, 0.025% BSA, 1 mM 
CaC12, and 3 I~M fura-2/acetoxymethylester.  The loaded cells (106 
cells/ml) were stimulated with 3G8 (0.7 #g/ml) and F(ab')2 of 
goat anti-mouse IgG (3/~g/ml). Fluorescence  changes  were moni- 
tored with an Alphascan spectrofluorimeter (Photon Technology 
International Inc.) at an excitation wavelength of 340 nm and an 
emission wavelength of 505 nm. [Ca2+]i was calibrated and com- 
puted as described (15). For inositol  phosphate  measurements,  trans- 
fectants were labeled with [3H]myo-inositol  (10 #Ci/ml) for 6 h 
in inositol-free RPMI 1640 with 10% dialyzed FCS. The cells (5 
x  106 cells/ml) were then stimulated with 3G8 (10/~g/ml) in the 
presence of LiC1. At various time points, the cells were lysed and 
soluble inositol phosphates were extracted with TCA, and applied 
to AG1-X8 ion exchange columns (Bio-Rad Laboratories, Rich- 
mond, CA) (16). For tyrosine phosphorylation analysis,  cells (2  x 
106 cells/ml) were stimulated (3 min for each incubation) with 
3G8 (5/~g/ml) or F(ab')2 of goat anti-mouse IgG (10/~g/ml) in 
addition to 3G8. 
Figure  2.  Identification of 
30-kD protein  as FceRI  fl subunit. 
Digitonin  lysates  of  MC9 cells  and 
P815 cells were immunoprecipi- 
tated  with anti-mouse  Fc3,RIIIA- 
oe or control  antibodies.  These  im- 
munoprecipitated samples were 
separated on  12.5% SDS-poly- 
acrylamide gels, transferred to 
Immobilon-P  sheet,  and incubated 
with l~I-labeled  anti-/~ antibody. 
Results and Discussion 
The mouse mast cell line MC9 expresses the ix, 8,  and 
3' subunits of FceRI and the ix subunit of Fc3"RIIIA,  as as- 
sessed by Northern blotting (data not shown). Previous studies 
have indicated that 3' associates with Fc3"RIIIA (6-8). To de- 
termine if the/3 chain of FceRI also associates with Fc3,RIIIA, 
MC9 cells were surface labeled with 12sI in the presence of 
0.01% digitonin, solubilized,  and immunoprecipitated using 
anti-Fc~RIIIA-ix antibody.  Anti-FcyRIIIA-ix coimmuno- 
precipitated the ligand binding subunit ix, the 3" chain, and 
in addition, a 30-kD protein. This 30-kD protein migrated 
with the same apparent molecular mass as the FceRI B subunit, 
shown by using anti-/3 antibody (Fig.  1 A). The association 
of the 30-kD protein was not the result of cross reactivity 
1Abbreviation used in this paper: [Ca2+]i, cytoplasmic-free  calcium. 
of the anti-Fcq,  RIIIA-ix antibody with FceRI-ix, as demon- 
strated by Fig. 1 B. COS cells transfected with FceRI-ix, -8, 
and -3' chains were surface labeled and immunoprecipitated 
with specific antibodies. Anti-~/and anti-y antibodies coim- 
munoprecipitated these three chains, whereas anti-Fc3'RIIIA-ix 
antibody did not (Fig.  1 B). 
To identify the 30-kD protein as 8, we prepared cell ly- 
sates from MC9 cells  and immunoprecipitated with anti- 
FcyRIIIA-ix antibody. The immunoprecipitated samples were 
separated on 12.5% SDS-polyacrylamide gels, transferred to 
membrane filters, and incubated with 12SI-labeled anti-B an- 
tibody. Isotype-matched control antibody precipitates of MC9 
cells and anti-FeyRIIIA-ix  precipitates  of P815 cells were run 
in parallel as controls. The mouse mastocytoma cell line P815 
expresses mouse Fc3'RIIIA-ix and 3, chains, but not B chain, 
as determined by both RNA and protein analysis (6,  22). 
B chain was only found in the MC9 lysates precipitated with 
anti-Fc3'RIIIA-ix specifically, but not in either control (Fig. 
Figure 1.  Association  of  30-kD protein  with 
Fc'IcRIIIA. Immunoprecipitation  analysis of 
MC9 cells (.4) and COS cells  transfected  with 
FcERI-a, -B, and -"r subunits  (/3). Cell  lysates 
were prepared  with digitonin  lysis  buffer,  were 
incubated with indicated  antibodies (C, con- 
trol antibody), and immune complexes were 
separated on 10% Tricine-SDS-polyacrylamide 
gels. 
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various combinations  of  Fc3,1LIIIA- 
~,3,"/,  and ~" chains. COS cells 
transfected  with various combina- 
tions of indicated  cDNAs were  la- 
behd with lzsI and immunoprecip- 
itated with indicated  antibodies,  a s 
and ho~ indicate  mouse  Ec3'RIIIA-oL 
and human  F~RIIIA-oe,  respectively. 
2). These results indicate that in mast cells, FceRI-3 is not 
only one component of FceRI but is also complexed with 
Fc3"RIIIA-ol  and 3' chains. 
To gain further insight into the nature of the association 
of 3  with Fc3'RIIIA, we used a transient cDNA expression 
system  in  COS  cells.  We  have  previously  shown  that 
Fc3'RIIIA-cx interacts directly with 3' or TCR/CD3  ~" chain 
in the endoplasmic reticulum. In the absence of 3' or ~'chains, 
the c~ subunit is rapidly degraded (13). One function of the 
3' subunit is in the assembly of the Fc3'RIIIA complex by 
protecting the c~ subunit from degradation. Therefore, we 
studied the requirement of 3  chain for surface expression of 
FcTRIIIA-o~ by flow cytometry analysis. As has been reported 
(6-8), cotransfection of the ol subunit with 3' resulted in a 
20-fold stimulation of surface expression of FcTRIIIA-o~. The 
3  subunit was unable to  substitute  for the 3' chain to en- 
hance surface expression of Fc3'RIIIA-oe.  The efficiency of 
the cell surface expression of COS cells transfected with o~, 
3,  and 3' was nearly identical to the cell surface expression 
observed with a  and 3' (data not shown). No difference in 
the kinetics of oL degradation was observed in pulse-chase 
experiments of COS cells transfected with either c~,3,3'  or 
o~,3'. These results are similar to what has been observed for 
human FceRI, in which 3' is sufficient for cell surface expres- 
sion of human FceRI-ot  (17). 
The 3' chain is closely related to the ~" chain of TCR/CD3 
complex (17-19) and is found complexed with the FcTRIIIA-c~ 
chain in NK cells (20, 21). Association of 3 with FcyRIIIA-a, 
%  or  ~" in  COS  cells  was  therefore examined by  coim- 
munoprecipitation experiments.  The 3 subunit was complexed 
with the 3' or ~" subunit (Fig.  3 A). COS cells transfected 
with FcTRIIIA-o~,  3, and 3' chains formed the complex ob- 
served in MC9 cells (Fig. 3 B), suggesting that the interac- 
tion of these three chains do not require cell type-specific 
proteins. Similar results were obtained when these subunits 
were translated in vitro in the presence of microsome mem- 
branes (data not shown). We have consistently observed in 
both MC-9 cells (Fig.  1 A) and COS cell transfectants (Fig. 
3) that the stoichiometry of 3  in complexes with o~, 3', or 
~" subunits varies depending on the antibody used for coim- 
munoprecipitation.  In Fig.  1 A,  the antibodies against olv 
or 3, chain are far more efficient in precipitating c~ chain than 
is the anti-3  antibody.  Similarly, in  Fig.  3 A,  anti-3  anti- 
body precipitates the 3-3' complex more efficiently than the 
3-~" complex. These differences might be related to the sta- 
bility of these various complexes in the presence of the anti- 
bodies used, partial dissociation of the receptors after solubili- 
zation, or may reflect the distribution of these complexes in 
vivo. 
FcyRIIIA on NK cells and macrophages is composed of 
at least three polypeptide chains: a ligand-recognition subunit 
(FcyRIIIA-o  0 and the associated dimeric 3' and ~" chains (5-8, 
20,  21), whereas on mast cells it is composed of o~, 3,  and 
3' chain. To characterize potential functional differences be- 
tween these FcTRIIIA isoforms (oe,3' and c~,3,3'), these com- 
plexes were reconstituted in transfected cells. Fc receptors for 
IgE and IgG are incapable of evoking proximal or distal signals 
in heterologous cells,  such as fibroblasts.  To study the sig- 
nalling capacity of these isoforms, we used the mouse mastocy- 
toma  cell  line  P815 (22)  for  transfection  of  the  human 
FcyRIIIA-ol and 3' subunits or, alternatively, the ol, 3, and 
3' subunits. Stable transfectants were obtained, and the den- 
sity of cell surface expression for these two isoforms was quan- 
titated by flow cytometry using the mAb 3G8. Comparable 
levels of Fc3'RIIIA-c~  were observed for each isoform. 
Immunoprecipitation experiments confirmed the associa- 
tion of c~ with the 3' subunit,  or alternatively with the 3 
and 3' subunits,  respectively (data not shown). The ability 
of 3G8 to activate an increase in [Ca2+]i and phosphatidyl- 
inositol 4,5-biphosphate (PIP2) hydrolysis in these transfected 
cells was evaluated. In both transfectants, a substantial in- 
crease in  [Ca  2+]i was seen in response to 3G8,  which was 
further  enhanced  by  crosslinking  using  F(ab')2  of  goat 
anti-mouse IgG (Fig.  4 A). Stimulation of Fc3'RIIIA with 
3G8 resulted in the generation of inositol phosphates in both 
transfectants (Fig. 4 B).  Since activation of a tyrosine kinase 
449  Kurosaki  et al. Figure 4.  Signal transducing  properties of P815 cells expressing or,  7  and ~,~,7.  [Ca2+]i increase (-4), inositol phosphate  generation  (B), and tyro- 
sine phosphorylation  (C) after stimulation  of or,  7  and ~,B,7 transfectants. Each lane of tyrosine phosphorylation  patterns  represents lysates from "~2 
x  106 cells. 
pathway by stimulation of TCR/CD3 (23), FceRI (24), and 
Fc'yRIIIA (25) has been established, we sought to determine 
whether 3G8 would stimulate tyrosine kinase activation in 
both transfectants. Western blot analysis using a mAb against 
phosphotyrosine revealed a 70-kD protein whose phosphory- 
lation was stimulated by 3G8 in the c~,7 transfectant, whereas 
in the cr  transfectant, tyrosine phosphorylation of this 
protein required additional crosslinking of the receptor. In 
contrast, tyrosine phosphorylation of a 90-kD protein in the 
o~,B,7 transfectant was stimulated with 3G8 only (Fig. 4 C). 
These results indicate that both the or,3' complex and the 
or,B,7 complex have the capability for transmitting early re- 
sponses. Antibodies to endogenous murine Fe3'Rs elicit similar 
signals  in P815  cells  (22,  29). 
The demonstration that FcTRIIIA on mast cells is corn- 
posed of or,/3, and 3' subunits raises the possibility that NK 
cells and macrophages, the other two cell types known to 
express FcTRIIIA, express a tetrameric form of this receptor. 
Although by RNA and protein analysis/~ expression is re- 
stricted to mast cells, structurally related molecules have been 
described on other hematopoietic cell types (26-28) and may 
be candidates for association with Fc3,RIIIA.  Indeed, the pres- 
ence of such molecules may account for the ability of P815 
cells to signal in the absence of a transfected ~  chain. The 
identification of these related molecules and their functional 
dissection will certainly shed light on the complexities of these 
receptors. In mast cells, however, Fc-mediated signaling has 
converged so  that  structurally distinct  ligands  result  in  a 
common signaling pathway by virtue of the exchange ofligand 
recognition subunits in  a tetrameric receptor complex. 
We are grateful to Dr. J.-P. Kinet of the National Institutes of Health for providing the antibody against 
the/3 chain of FceRI, to Dr. H. Sabe of The Rockefeller University for his assistance  with Western blot- 
ting experiments, to Dr. H. Metzger of the National Institutes of Health for his comments on the manu- 
script, and to Mari Kurosaki for technical assistance. 
This work was supported by grants to J. V. Ravetch from the National Institutes of Health. T. Kurosaki 
is an Adler Fellow and Cohen Fellow in Biomedical Research; I. Gander is supported from the Deutsche 
Froschungsgemeinschaft; U. Wirthmueller is supported by the Swiss National Science Foundation. 
Address correspondence to Jeffrey V. Ravetch, Laboratory of Biochemical Genetics, Molecular Biology 
Program,  Sloan-Kettering Institute,  1275 York Avenue, New York, NY 10021. 
Received  for publication 15 October 1991. 
450  FceRI-B  Is Associated with Mast Cell  FcTRIII References 
1.  Ravetch, J.V., andJ.-P. Kinet. 1991. Fc Receptors. Annu. R~ 
ImmunoL  9:457. 
2.  Ravetch, J.V., and C.L. Anderson. 1989. Fc'yR Family: pro- 
teins, transcripts, and genes. In Fc Receptors and the Action 
of Antibodies.  H.  Metzger,  editor.  American  Society of 
Microbiology, Washington, DC. 221-235. 
3.  Kinet, J.-P. 1990. Antibody-cell  interactions: Fc receptors. Cell. 
57:351. 
4,  Blank, U., C. Ra, L. Miller, K. White, H. Metzger, and J.-P. 
Kinet. 1989. Complete structure and expression in transfected 
cells of high affinity IgE receptor. Nature (Lond.). 337:187. 
5.  Ravetch, J.V., and B. Perussia. 1989. Alternative membrane 
forms of Fc3,RIII (CD16) on human neutral killer cells and 
neutrophils: cell type-specific  expression  of two genes that differ 
in single nucleotide substitutions. J. Exp.  Med.  170:481. 
6.  Ra, C., M.-H.E. Jouvin, U. Blank, and J.-P. Kinet. 1989. A 
macrophage Fc3' receptor and the mast cell receptor for IgE 
share an identical subunit. Nature (Lond.). 341:752. 
7.  Hibbs, M.L., P. Selvaraj, O. Carpen, O.A. Springer, H. Kuster, 
M. Jouvin, and J.-P. Kinet. 1989. Mechanisms for regulating 
expression of membrane isoforms of Fc3,RIII (CD16). Science 
(Wash. DC).  246:1608. 
8.  Kurosaki, T., and J.V. Ravetch. 1989. A single amino acid in 
the glycosyl phosphatidylinositol attachment domain deter- 
mines the membrane topology of Fc"/RIII. Nature (Lond.). 
342:805. 
9.  Cassatdla, M.A., I. Anegon, M.C. Cuturi, P. Griskey,  G. Trin- 
chieri, and B. Perussia. 1989. Fc~/R (CD16) interaction with 
ligand induces Ca  2§ mobilization and phosphoinositide turn- 
over in human natural killer cells.  J. Exp.  Med.  169:549. 
10.  Froese,  A. 1984. Receptors for IgE on mast cells and basophils. 
Prog. Allergy.  34:142. 
11.  Kinet, J.oP., U. Blank, C. Ra, K. White, H. Metzger, and 
J.  Kochan. 1988. Isolation and characterization of cDNAs 
coding for the B subunit of the high-affinity receptor for im- 
munoglobulin E. Proc. Natl. Acad. Sci. USA.  85:6483. 
12.  Morgenstern, J.P., and H. Land. 1990. Advanced  mammalian 
gene transfer: high titre retroviral vectors with multiple drug 
selection markers and a complementary helper-free packaging 
cell line. Nucleic Acids Res.  18:3587. 
13.  Kurosaki, T., I. Gander, and J.V. Ravetch. 1991. A subunit 
common to an IgG Fc receptor and the T-cell receptor mediates 
assembly through different interactions. Proc Natl. Acad. Sci. 
USA.  88:3837. 
14.  Rivera,  J., J.-P. Kinet, J. Kim, C. Pucillo, and H. Metzger. 
1988. Studies with a monoclonal antibody to the B subunit 
of the receptor with high affinity for immunoglobulin E. Mol. 
Immunol.  25:647. 
15.  Grynkiewicz, G., H. Poenie, and R.Y. Tsien. 1985. A new 
generation of Ca  2+ indicators with greatly improved fluores- 
cence properties. J. Biol. Chem.  260:3440. 
16.  Berridge, MJ., R.M.C. Dawson, C.P. Downes, J.P. Heslop, 
and R.F. Irvine. 1983. Changes in the levels ofinositol phos- 
phates after agonist-dependent hydrolysis  of membrane phos- 
phoinositides. Biockem. J.  212:473. 
17. Miller, L., U. Blank, H. Metzger, and J.-P. Kinet. 1989. Ex- 
pression of high-affinity binding of human immunoglobulin 
E by transfected cells. Science (Wash. IX?),  244:334. 
18.  Weissman, A.M., D. Hou, D.G. Orloff, W.S. Modi, H. Seu- 
anez, S.J. O'Brien, and R.D. Klausner. 1988. Molecular  cloning 
and chromosomal localization of the human T-cell receptor ~" 
chain: Distinction from the molecular  CD3 complex.  Pwa Natl. 
Acad. Sci. USA.  85:9709. 
19.  Ra, C., M.-H.E. Jouvin, andJ.-P. Kinet. 1989. Complete struc- 
ture of the mouse mast cell receptor for IgE (FceRI) and sur- 
face expression of chimeric receptors (rat-mouse-human) on 
transfected cells.  J. Biol. Chem.  264:15323. 
20.  Lanier, L.L., G. Yu, and J.p. Phillips. 1989. Co-association of 
CD3 with a receptor (CD16) for IgG Fc on human NK ceils. 
Nature (Lond.). 342:803. 
21.  Anderson, P., M. Calligiuri, C. O'Brian, T. Manley,  J. Ritz, 
and S.F. Schlossman. 1990. Fc3"RIII  (CD16) is included in the 
~" NK receptor complex  expressed  by human natural killer cells. 
Proc Natl. Acad. Sci. USA.  87:2274. 
22.  Miller, L., G. Alber, N. Varin-Blank, R. Ludowyke, and H. 
Metzger. 1990. Transmembrane  signaling  in P815 mastocytoma 
cells by transfected IgE receptors.  J. Biol. Chem.  265:12444. 
23.  Klausner, R.D.,  and L.E.  Samelson. 1991. T  cell antigen 
receptor activation pathways: the tyrosine kinase connection. 
Cell. 64:875. 
24.  Benhamou, M., J.S. Gutkind, K.C. Robbins, and R.P. Siraga- 
nian. 1990. Tyrosine  phosphorylation coupled to IgE receptor- 
mediated signal transduction and histamine release. Proc. Natl. 
Acad. Sci. USA.  87:5327. 
25.  Einspahr, K.J., R.T. Abraham, B.A. Binstadt, Y. Uehara, and 
P.J. Leibson. 1991. Tyrosine  phosphorylation provides an early 
and requisite signal for the activation  of  natural killer cell cyto- 
toxic function. Proa Natl. Acad. Sci.  USA.  88:6279. 
26.  Classon, B.J., A.F. Williams, A.C.  Willis, B. Seed, and I. 
Stamenkovic. 1989. The primary structure of human leuko- 
cyte antigen CD37,  a species homologne of the rat MRC 
OX-44 antigen, f  Ext~  Med.  169:1497. 
27.  Angelisova, P., C. Vlcek, I. Stefanova,  M. Lipoldova, and V. 
Horejsi. 1990. The human leucocyte surface antigen CD53 is 
a protein structurally similar to the CD37 and MKC OX-44 
antigens. Immunogenetics. 32:281. 
28.  Stamenkovic, I., and B. Seed. 1988. Analysis of two cDNA 
clones encoding the B lymphocyte antigen CD20 (B1, Bp35), 
a type III integral membrane protein.f Extx Med.  167:1975. 
29. Alber, G., L. Miller, C.L. Jelsema, N. Varin-Bhnk, and H. 
Metzger. 1991. Structure-function relationships in the mast 
cell high affinity receptor for IgE. J. Biol. Chem.  266:22613. 
451  Kurosaki  et al. 